Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Public ClinicalTrials.gov record NCT03257033. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.
Study identification
- NCT ID
- NCT03257033
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 190 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 12, 2018 (Actual)
- Primary completion
- Jun 2027 (Estimated)
- Completion
- Sep 2027 (Estimated)
- Last update posted
- Sep 30, 2026
2018 – 2027
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VA Loma Linda Healthcare System | Loma Linda | California | 92357 | — |
| Sutter Cancer Center Sacramento | Sacramento | California | 95816 | — |
| Sibley Memorial Hospital - a member of Johns Hopkins medicine | Washington D.C. | District of Columbia | 20016 | — |
| 21st Century Oncology | Fort Myers | Florida | 33907 | — |
| Miami Cancer Center | Miami | Florida | 33167 | — |
| Sarasota Memorial Health Care System | Sarasota | Florida | 34329 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| ASCLEPES Research Centers | Weeki Wachee | Florida | 34607 | — |
| University of Iowa Hospitals and Clinics - Holden Comprehensive Cancer Center | Iowa City | Iowa | 52242 | — |
| Medstar Franklin Square | Baltimore | Maryland | 21237 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03766 | — |
| MD Anderson Cancer Center at Cooper Hospital | Camden | New Jersey | 08103 | — |
| Feinstein Institutes for Medical Research - Northwell Health | Manhasset | New York | 11030 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Montefiore Hospital | The Bronx | New York | 10461 | — |
| Levine Cancer Institute - Atrium Health | Charlotte | North Carolina | 28204 | — |
| East Carolina University | Greenville | North Carolina | 27834 | — |
| Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | North Carolina | 27157 | — |
| Oklahoma University - Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15232 | — |
| Medical University of South Carolina - Hollings Cancer Center | Charleston | South Carolina | 29425 | — |
| Prisma Health (formerly Greenville Health System) | Greenville | South Carolina | 29605 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| West Virginia University Medicine | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03257033, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03257033 live on ClinicalTrials.gov.